Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suxiao Jiuxin Pills for coronary heart disease with nitrate intolerance
ChiCTR2100050066Phase 4Recruiting
- Sponsor
- Shandong Provincial Hospital of Traditional Chinese Medicine
- Start
- Aug 2021
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Suxiao Jiuxin Pills in coronary arteriosclerosis and angina pectoris (2 arms), sponsored by Shandong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Electrocardiogram, Changes of main symptoms of traditional Chinese medicine and 3 more. Started Aug 2021; status: recruiting.
02
Drugs
Suxiao Jiuxin Pills
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on ChiCTR2100050066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050066.